Clarivate Stock News

NEW YORK, Feb. 23, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Clarivate Plc (NYSE: CLVT) between February 26, 2021 and December 27, 2021, inclusive (the "Class Period"), of the important March 25, 2022 lead…

RADNOR, Pa., Feb. 18, 2022 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Clarivate Plc (“Clarivate”) ( NYSE: CLVT; CLVT-PA ). The action charges Clarivate with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects. As a result of Clarivate’s materially misleading statements to the public, Clarivate investors have suffered significant losses.

Investors can contact the law firm at no cost to learn more about recovering their losses

BENSALEM, Pa. , Feb. 15, 2022 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Clarivate Plc ("Clarivate" or the "Company") (NYSE: CLVT ). Class Period: February 26, 2021 – December 27, 2021 Lead Plaintiff Deadline: March 25, 2022 Investors suffering losses on their Clarivate investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected] . The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors that: (1) Clarivate maintained defective disclosure … Full story available on Benzinga.com

NEW YORK, Feb. 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP , NRXPW)), Clarivate Plc (NYSE: CLVT ), Bumble, Inc. (NASDAQ: BMBL ), and Standard Lithium Ltd. (NYSEAMERICAN: SLI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. NRx Pharmaceuticals, Inc. (NASDAQ: NRXP , NRXPW)) Class Period: June 1, 2021 November 4, 2021 Lead Plaintiff Deadline: March 21, 2022 NRx is a clinical-stage small molecule pharmaceutical company that develops various therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The Company''s products include, among others, ZYESAMI, an investigational pre-commercial drug for COVID-19 related respiratory failure.

NEW YORK--(BUSINESS WIRE)-- #CLVT--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Clarivate Plc (NYSE: CLVT) between February 26, 2021 and December 27, 2021, inclusive (the Class Period). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2022. SO WHAT: If you purchased Clarivate securities during the Class Period you

RADNOR, Pa., Feb. 10, 2022 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Clarivate Plc (Clarivate) ( NYSE: CLVT; CLVT-PA ). The action charges Clarivate with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the companys business, operations, and prospects. As a result of Clarivates materially misleading statements to the public, Clarivate investors have suffered significant losses.

NEW YORK, Feb. 9, 2022 /PRNewswire/ -- The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Clarivate Plc. Shareholders who purchased shares of CLVT during the class period listed are encouraged to contact the firm regarding…

NEW YORK, Feb. 8, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Clarivate Plc (NYSE: CLVT) alleging that the Company violated federal securities laws. Class Period: February 26, 2021 to December 27, 2021 Lead…

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.

Barclays has cut to equal weight from neutral due to valuation and what it calls spotty organic execution.

The heavy selling pressure might have exhausted for Clarivate PLC (CLVT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analy

Clarivate PLC (CLVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

We have identified names that look bearish and may present interesting investing opportunities on the short side. Using technical analysis of the charts of those stocks and appropriate recent actions,

Janney Montgomery Scott LLC bought a new position in shares of Clarivate Plc (NYSE:CLVT) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 96,727 shares of the companys stock, valued at approximately $2,118,000. Other large investors also recently made changes to their positions in the company. Berman Capital Advisors LLC raised its position in []